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Abstract: A current research topic of great interest is the study of the therapeutic properties of
plants and of their bioactive secondary metabolites. Plants have been used to treat all types of health
problems from allergies to cancer, in addition to their use in the perfumery industry and as food.
Hedychium species are among those plants used in folk medicine in several countries and several
works have been reported to verify if and how effectively these plants exert the effects reported in folk
medicine, studying their essential oils, extracts and pure secondary metabolites. Hedychium coronarium
and Hedychium spicatum are the most studied species. Interesting compounds have been identified like
coronarin D, which possesses antibacterial, antifungal and antitumor activities, as well as isocoronarin
D, linalool and villosin that exhibit better cytotoxicity towards tumor cell lines than the reference
compounds used, with villosin not affecting the non-tumor cell line. Linalool and α-pinene are the
most active compounds found in Hedychium essential oils, while β-pinene is identified as the most
widespread compound, being reported in 12 different Hedychium species. Since only some Hedychium
species have been investigated, this review hopes to shed some light on the uncharted territory that is
the Hedychium genus.
Keywords: Hedychium; traditional medicine; coronarin D; villosin; anti-acetylcholinesterase;
antidiabetic; anti-inflammatory; antimicrobial; antioxidant; antitumor
1. Introduction
Since the beginning of the history of mankind there was always a connection between plants and
human health, as they were used as food and medicines [1]. The traditional herbal medicine outlined
the foundations from which modern medicine developed and is still largely practiced around the
world [2], particularly in Asian and developing countries [3,4]. This popular knowledge, also known
as folk medicine, gives a good indication to scientists looking for sources of new compounds with
pharmaceutical potential. Thus, medicinal plants and their derived natural compounds have become
an increasing topic of investigation and interest [5,6].
According to “The Plant List” database [7], the genus Hedychium (Zingiberaceae family) comprises
93 species with accepted scientific plant names that, with the exception of Hedychium peregrinum N.E.Br.
that is endemic to Madagascar [8], are native to wooded habitats in tropical and temperate Asia
(i.e., China, Indian subcontinent and Southeast Asia) [8–10]. Members of this genus are well distributed
worldwide, being easily found particularly throughout tropical Asia, Australia, Fiji, New Caledonia,
New Guinea, New Hebrides, Samoa and the Solomon Islands [8,10,11], with some species being
considered invasive in some places: e.g., Hedychium coronarium J. Koenig in Brazil [12] and Hedychium
gardnerianum Sheppard ex Ker-Gawl. in Azores Archipelago [13] and Hawaii [14].
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Hedychium species are medium-size rhizomatous perennial monocotyledonous plants that can be
easily recognized by their characteristic striking foliage and terminal spikes that produce diversified
numerous short-lived flamboyant flowers with several hues and fragrances varying depending on the
species [15]. These features give them a high ornamental value, being cultivated worldwide mostly for
this purpose and for its use in the perfumery industry, since, besides the aromatic flowers, Hedychium
species rhizomes also originate strongly scented oils [16,17].
The use of Hedychium species in folk medicine is common in several countries since they are
easily harvested directly from nature or obtained at local markets [18]. These plants are reported to
possess analgesic, antimicrobial, antidiabetic, anti-inflammatory, antitumor, anti-allergic, anthelmintic
and antioxidant properties [19–22]. In Table 1, it is summarized the different Hedychium species with
reported traditional medicinal use in literature over different geographic areas.





Traditional Medicinal Use Preparation and/orAdministration
Hedychium sp. [23] Myanmar [23]
Cuts and wounds [23] Cataplasms of crushed leaves andrhizomes [23]
Weak blood circulation and to
accelerate postpartum recovery [23]
Decoction of rhizomes is
drunk [23]
Hedychium coccineum
Buch.-Ham. ex Sm. India [24] Jaundice [24] Decoction of rhizomes [24]
H. coronarium
Brazil [25,26]
Anti-inflammatory and sedative [25]
Leaves infusion [25,26]
Headache and fever [26]
China [27] Diabetes, headache, inflammation,rheumatism and skin diseases [27] Rhizomes [27]
Colombia [28] Snake bites [28] Decoction of rhizomes [28]
India [16,29–31]
Stimulant tonic, carminative,
headache, fever, diphtheria and
diabetes [16,29,30]
Grinded rhizomes [16,29,30]
Abdominal pain [31] 10 g of sun-dried rhizome powdermixed with cooked vegetables [31]





Decoction of rhizomes [33]
Rubefacient [33] Cataplasm of fresh rhizomes [33]
Rheumatism [33]
Rub affected areas with paste from
crushed rhizomes cooked in
mustard oil with garlic and
crushed camphor bark [33]
Nicaragua [34] Snake bites [34] Decoction of rhizomes [34]
Peru [35] Soothing and rheumatism [35] Bath is prepared with the aerialpart [35]
Thailand [16,36]
Sore and stiff joints [16] Application of boiled leaves inaffect areas [16]
Tonsillitis [16] Decoction of the stem isgargled [16]
Mosquito repellent [36] Oil from the plant [36]
Vietnam [37] Diabetes, headache, inflammation,rheumatism and skin diseases [37] Rhizomes [37]






Traditional Medicinal Use Preparation and/orAdministration
Hedychium
cylindricum Ridl. Malaysia [38]
Antirheumatic, febrifuge, tonic,




Buch.-Ham. ex Sm. Nepal [39] Fever [39]




Madagascar [40] Caries [40]
Squeezed leaves liquid is applied
in cotton and then placed in the
affected cavity [40]
Mauritius [33] Rheumatism [33]
Rub affected areas with paste from










blood diseases, hiccough and
vomiting [42]
3 to 4 g of rhizome powder two
times a day [42]
Asthma, body pain, inflammation
and laxative [43]
1 g dried rhizome powder twice a
day [43]
Diarrhea, fever, liver problems and
pain [21]
Spoonful of dried rhizome
powder thrice a day [21]
Expectorant, stimulant, stomachic,
tonic and vasodilator [21] Cup of the rhizome decoction
twice a day [21]
Snake bites [44]
Nepal [39] Indigestion and high fever [39] Decoction of rhizome three to fiveteaspoons twice a day [39]
In addition to the traditional medicinal uses stated in Table 1, Hedychium species are also included
in the diet of some populations, like in Thailand where the flowers of Hedychium forrestii Diels can be
boiled to become a beverage [45] or in India where the fruit of H. spicatum may be cooked and eaten
with lentils in savory dishes [42]. Moreover, the rhizome of H. coronarium is also included in the diet of
some populations of South East Asia, being consumed as a vegetable or as a food flavoring spice [46].
The traditional uses mentioned above show that several Hedychium species are used to treat a
wide spectrum of diseases. These uses also show that Hedychium species should be considered as
promising sources of new bioactive natural compounds and that is why these species have been the
target of research by the scientific community. In recent years, several studies have been published on
the phytochemical characterization of Hedychium species, as well as on the evaluation of the biological
activities exhibited by their organic extracts, essential oils and pure compounds, with some of them
showing very interesting results. Recently, literature reviews have been published focusing only
on specific species, i.e., H. coronarium [20,47] and H. spicatum [21,48]. This work aims to update the
available information that were not mentioned in the previous reviews, as well as involving all the
other Hedychium species, their bioactivities and their bioactive isolated compounds. The research for
this review was made combining the terms Hedychium, phytochemical and biological activities in
the databases Web of Science, PubMed and Scopus and were considered only the published works
involving Hedychium species whose binominal Latin name is an accepted name on the The Plant List
database [7].
2. In Vitro and In Vivo Activities of Hedychium Extracts and Essential Oils
Taking into account the traditional uses of Hedychium species, several works have been carried
out to elucidate how effectively plants can exert the reported biological effects. The following is a
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compilation and discussion of the most current works on this subject, in which essential oils and
extracts of Hedychium species are studied and their biological activities are ascertained.
2.1. Anti-Acetylcholinesterase
The inhibition of the enzyme acetylcholinesterase (AChE) is one of the pathways to countering
the cholinergic deficit associated with cognitive dysfunction diseases like in Alzheimer’s disease [49].
Arruda and colleagues [50] showed that the leaf essential oil of H. gardnerianum collected from four
different locations could inhibit AChE action, mainly mixed inhibition, presenting IC50 values ranging
from 1.03 ± 0.14 mg/mL to 1.37 ± 0.27 mg/mL, a value not statistically different from the value displayed
by the AChE inhibitor standard compound α-pinene that presented an IC50 value of 1.43 ± 0.07 mg/mL.
This work showed no statistically significant difference between the activity of samples taken in
different geographical areas [50].
2.2. Antidiabetic
Deficiency in insulin secretion, insulin action or both, results in chronic hyperglycemia, the main
characteristic of diabetes mellitus [51], the main treatment to this condition being the use of anti-diabetic
drugs that can control glucose levels in the blood [52].
An in vivo study [53] was carried out to assess the effect of H. coronarium aqueous extract to
lower blood glucose level in induced-type 2 diabetes mellitus (T2DM) animal models (streptozotocin
(STZ)-induced T2DM Wistar rats and C57BKSdb/db mice, a mice model with a mutation that results
in chronic hyperglycemia, pancreatic beta cell atrophy, low insulin level and obesity). After 28 days,
the daily dose of H. coronarium aqueous extract (8.928 mg/kg for the STZ-induced T2DM rats and
17.71 mg/kg for the C57BKSdb/db mice) significantly increased glucose tolerance in both diabetic models,
when compared with the group treated with distilled water (control group). In addition, the treatment
also helped to maintain optimal β-cell structure, moderately increased insulin, improved the lipid
profile and decreased aldosterone level in STZ-induced T2DM model.
In another in vivo assay [54], after 14 days of treatment, using an oral dose of 0.3 mL of essential
oil from rhizomes of H. spicatum, was observed the reduction of blood glucose and urea levels in rats
with diabetes induced by intraperitoneal injection of a solution of alloxan monohydrate (150 mg/kg).
This result is similar to those obtained in the group of rats treated with the reference drug glibenclemide.
Furthermore, it was noticed that the Islets of Langerhans regained their normal shape after the treatment
period [54].
2.3. Anti-Inflammatory
Inflammation is a vital defense mechanism that works to ensure good health [55], but uncontrolled
inflammation may lead to serious repercussions [56] and so it is important to continue research into
products that can help in its control.
An in vivo study [57] with rats demonstrated the anti-inflammatory effect of a single oral dose
(200 mg/kg) of aqueous and ethanolic extracts of H. spicatum rhizome against carrageenan-induced
paw edema. Measurements of the edema volume were taken in a successive interval of 1 h, 2 h
and 3 h and significant decrease in paw edema volume was detected since the beginning, with the
aqueous extract reporting a 28.10% decrease in inflammation and the ethanolic extract a 25.62%
decrease in inflammation. Although none of the extracts performed as well as the positive control
compound indomethacin (41.32% decrease in inflammation), they both proved to present no acute
toxicity in a concentration as high as 2000 mg/kg, with the rats never showing secondary toxic effects
like coma, convulsion, salivation, increased motor activity or death. This dose of 2000 mg/kg was
previously utilized in a similar work [58] where the ethanolic extract of H. spicatum reported a 55.54%
of anti-inflammatory activity inhibition against carageenan-induced edema in rats.
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2.4. Antimicrobial
A healthy human body is a symbiosis between human and microbial components [59]. However,
sometimes that symbiotic balance can be disturbed, and human health can be impaired by pathogenic
microorganisms (i.e., bacteria, fungi, parasites or viruses), the use of effective antimicrobial drugs being
needed to restore health normality [60,61].
Noriega et al. [62] showed that, among five different plants, the essential oil of H. coronarium rhizome
exhibited the most relevant antibacterial activity against Listeria grayi (MIC value = 0.45 mg/mL) and
Streptococcus mutans (MIC value = 0.18 mg/mL) and even against the Gram-negative bacteria Klebsiell
oxytoca (MIC value = 0.90 mg/mL). The authors point out the compounds 1,8-cineole and terpinen-4-ol
as responsible for the reported activity [62]. In another work [63], H. coronarium leaves essential oil
was also pointed out to have antibacterial activity against different bacterial strains, i.e., Escherichia
coli (MIC value = 3.90 µL/mL), Staphylococcus aureus (MIC value = 7.81 µL/mL) and Pseudomonas
aeruginosa (MIC value = 15.62 µL/mL). These two works are presented here also as examples of
two constraints which are common in a variety of scientific papers. First, no work reports, as a
comparative term, the activity exhibited by a standard antibacterial compound, determined under the
same experimental conditions as the essential oil samples. Without these data it is very difficult to
assess the true potential of the samples tested. Second, the MIC values are expressed in non-comparable
units. Fortunately, one of the works [62] presents the density of the essential oil, making it possible to
convert one of the sets of results [against Listeria grayi (MIC value = 0.50 µL/mL), Streptococcus mutans
(MIC value = 0.20 µL/mL), Klebsiell oxytoca (MIC value = 1.0 µL /mL)], allowing to conclude that the
essential oil from rhizome is more active as antibacterial agent than leaves essential oil. Regrettably,
some papers do not present enough experimental data to allow a unit conversion. Additionally,
Ray et al. [64] reported that the essential oil extracted from the rhizome of H. coronarium is an effective
antifungal agent since it exhibited activity against Candida albicans (MIC = 3.12 µg/mL), Aspergillus
flavus and Fusarium oxysporum (MIC value of 6.25 µg/mL for both species), these MIC values being
much lower than those reported for antibacterial activity by Noriega et al. [62].
Another work [65] found that 20 µL of Hedychium matthewii S. Thomas, B. Mani & S. J. Britto
rhizome essential oil could be as effective as 30 µg of the standard antibiotic amoxicillin, since it exerted
nearly the same growth inhibition effect against several strains of Gram- positive and Gram-negative
bacteria (viz. Bacillus cereus, Staphylococcus aureus, Enterobacter aerogens, Salmonella paratyphi, Salmonella
typhii, Escherichia coli, Vibrio parahaemolyticus, Proteus vulgaris, Klebsiella pneumoniae and Pseudomonas
aeruginosa). Furthermore, it could be pointed out that Streptococcus haemolyticus and Vibrio cholerae were
more susceptible towards the essential oil (20 µL) than towards amoxicillin (30 µg).
The activity of H. spicatum flowers essential oil was evaluated against the Gram-negative bacteria
Borrelia burgdorferi in stationary phase cycle and it was found out that a 0.1% (v/v) essential oil
concentration could eradicate B. burgdorferi (100 µL) with no regrowth [66]. This is one of the few
published works that evaluates the antibacterial activity in the stationary-phase of growth.
A different work [67] found that a combination treatment using essential oil of H. spicatum
rhizomes and γ-radiation was effective against Fusarium graminearum, inhibiting both the fungal
growth in maize grains and the production of the toxic mycotoxins deoxynivalenol and zearalenone
in a dose-dependent way, with a complete inhibition at the concentration of essential oil 1.89 mg/g
and 4.1 kGy of γ-radiation. Combinational treatment proved to be better than individual treatment,
since complete inhibition of F. graminearum required the essential oil concentration of 3.15 mg/g or
6 kGy of γ-radiation.
It is not just the essential oils of Hedychium species that have been evaluated concerning
antimicrobial activity. Arora and Mazumder [68] evaluated the activity of H. spicatum rhizomes
methanolic extract and the antibiotic ciprofloxacin against different bacterial strains (viz. Shigella boydii,
Shigella soneii, Shigella flexneri, B. cereus, V. cholerae, E. coli, S. aureus, Ps. aeruginosa and K. pneumoniae) at
the concentrations of 200 to 1200 µg/mL. The results showed a similar inhibition effect for both antibiotic
and extract, B. subtilis being the bacteria with greater susceptibility to the extract and antibiotic.
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Another work [69] evaluated the anthelmintic activity of methanolic, ethanolic, hydromethanolic,
hydroethanolic and aqueous rhizome extracts of H. spicatum against Hemonchus contortus, with the
results showing that the methanolic extract were as effective as the positive control compound
thiabendazole on time taken for paralysis and time taken for death (tested concentrations 20, 40 and
60 mg/mL).
2.5. Antioxidant
Oxygen metabolism is fundamental for human life but its reaction products, like reactive oxygen
species (ROS), can increase oxidative stress, causing damage to cells and tissues [70] that, with time,
leads to the development or aggravation of several chronic diseases [71]. Thus, therapeutic antioxidant
agents are key to mitigate the oxidative stress impact in human health, with natural plant-derived
products being the main investigation focus of search [72].
Noriega et al. [62] evaluated the antioxidant activity of the essential oil extracted from the
rhizome of H. coronarium, reporting IC50 values of 9.04 ± 0.55 mg/mL and 2.87 ± 0.17 mg/mL for
1,1-Diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid
(ABTS) assays, respectively. In a similar work, Ray and colleagues [64] also evaluated the antioxidant
activity of the essential oil from H. coronarium rhizome, but from ten distinct regions of India, obtaining
activity values higher than those indicated in the work of Noriega et al. [62] (IC50 values range from
0.57 to 2.19 mg/mL for the DPPH assay; and 0.12 to 0.67 mg/mL for the ABTS assay), but lower than
the positive control 2,6-di-tert-butyl-4-methylphenol (BHT) (IC50 = 0.12 ± 0.01 mg/mL on the DPPH
assay, and 0.08 ± 0.01 mg/mL on the ABTS assay). It could be pointed out that Ray et al. [64] also
demonstrate, very clearly, that the geographical origin of the samples is a relevant variable for the level
of activity displayed. The same conclusion can be drawn from the results obtained by Arruda et al. [50],
where the DPPH antioxidant activity of H. gardnerianum leaf essential oil collected from four different
locations ranged from EC50 = 8.46 ± 0.90 µg/mL to 31.14 ± 2.70 µg/mL (EC50 = 31.00 ± 0.19 µg/mL
for BHT). In a more recent work, Ray et al., [73] studied the antioxidant activity of Hedychium greenii
W. W. Smith. and Hedychium gracile Roxb. rhizomes essential oils by the same methodology (DPPH and
ABTS assays), with H. greenii showing higher antioxidant activity (IC50 values of 16.73 ± 0.19 µg/mL for
DPPH and 12.18 ± 0.16 µg/mL for ABTS assays) than H. gracile sample (IC50 values of 46.94 ± 0.6 µg/mL
for DPPH and 31.13 ± 0.29 µg/mL for ABTS assays), and slightly higher than the positive control BHT
(IC50 = 18.94 ± 0.3 µg/mL and IC50 = 14.21 ± 0.27 µg/mL for DPPH and ABTS assays, respectively).
These results [73], when compared with those obtained in the works mentioned above [50,64], show that
the level of antioxidant activity of essential oils exhibits variability between different Hedychium species
(IC50 values range from 8.46 to 2190 µg/mL) higher than geographical variability (IC50 values range
from 0.57 to 2.19 mg/mL for the DPPH assay).
Zhao et al. [74] compared essential oils and ethanolic extracts from rhizomes of different species
from the Zingiberaceae family in terms of its antioxidant capacity by DPPH assay. The ethanol extracts
of H. coronarium and H. gardnerianum proved to be the best antioxidant samples presenting IC50
values of 0.94 µg/mL and 1.59 µg/mL, respectively, even better than the reference compounds trolox
(IC50 = 10.19 µg/mL) or ascorbic acid (IC50 = 8.37 µg/mL). Essential oils of these plants were also tested
but unfortunately the authors presented the results as a graphic which does not allow the reading of
numerical values of antioxidant activity.
Usha et al. [75] compared the hydromethanolic rhizome extract of different species also from
Zingiberaceae family in terms of its antioxidant capacity and found out that Hedychium sp. reported the
best results, with the lowest IC50 value on DPPH assay (36.4 µg/mL). This activity was correlated with
its high phenol and flavonoid content. Unfortunately, the authors do not specify neither the Hedychium
species that was used nor the IC50 value of the ascorbic acid used as positive control, which makes
impossible to compare with other published works.
Another work [69] evaluated, through ABTS, DPPH and nitric oxide (NO) free radical scavenging
assays, the antioxidant activity of methanolic, ethanolic, hydromethanolic, hydroethanolic and aqueous
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rhizome extracts of H. spicatum. The results showed the methanolic extract as the most antioxidant
extract, presenting the lowest EC50 values for all the assays (EC50 ABTS value = 24.93 mg/mL, EC50
DPPH value = 8.31 mg/mL and EC50 NO value = 3.57 mg/mL). However, this extract is much less
active than the positive control ascorbic acid (EC50 = 1.63 mg/mL to ABTS assay, EC50 = 0.049 mg/mL
to DPPH assay and EC50 = 0.10 mg/mL to NO assay) and since the extract EC50 values are very high,
it should be considered an inactive extract.
In an in vivo study, Choudhary and Singh [76] demonstrated the antioxidant potential of
H. spicatum rhizome, since an improvement in the oxidative stress state of white leghorn cockerels
(Gallus gallus domesticus) was observed after the rhizome powder was added to the animal diet,
following chronic exposure to indoxacarb.
2.6. Antitumor
Cancer is a complex disease that is a major cause of death worldwide [77], with several treatments
but no cure [78]. In the light of the aggressive and not always effective treatments in current medicine,
the demand for safer and better anticancer compounds have turned the search to natural products as
another therapeutic approach to cancer [79].
Ray and colleagues [80] demonstrated the antiproliferative time-dependent effect of H. coronarium
rhizome ethanol extract against human cervical carcinoma HeLa cells, without affecting the viability
of non-tumor human umbilical vein endothelial cells (HUVEC). After 24, 48 and 72 h of incubation,
the observed IC50 values were 17.18 ± 0.46, 15.32 ± 0.68 and 12.57 ± 0.32 µg/mL, respectively.
Although the positive control drug camphothecin presented a far greater inhibitory effect against
HeLa cells (IC50 values of 0.82 to 0.98 µg/mL), it is also more toxic to the HUVEC cells (IC50 value for
24 h = 10.13 ± 0.62 µg/mL) than the H. coronarium ethanol extract (IC50 value for 24 h > 320 µg/mL),
which means that the extract presents a higher selective cytotoxicity. In addition, the same study
shed some light on the mechanism whereby the extract exerts its antitumor activity. It denotes
the modulation of the expression of proapoptotic and antiapoptotic protein levels together with an
increase of ROS generation and consequent oxidative stress induction in HeLa cells that led to an
apoptosis-mediated G1 phase cell arrest as the main cause of HeLa cells migratory capacity inhibition.
In another study [81], the methanolic extract of H. spicatum rhizomes was described as possessing
a dose-dependent cytotoxicity activity against human liver hepatocellular carcinoma cell line HepG2,
testing concentrations in the range of 25 to 3000 µg/mL. The concentrations tested and the IC50 value
(281.917 µg/mL) are very high, and the authors do not provide the cytotoxicity of a positive control
nor do they evaluate the effects of such concentrations on non-tumor cells. The results obtained in
the studies performed in these conditions, should be considered with many reservations as the effects
observed using such high concentrations are non-specific. On the other hand, the researchers should
take into account that 20 µg/mL is the limit established by the National Cancer Institute to consider an
extract active enough to justify continuing its study [82], so the tested extract should be considered
inactive against HepG2 cells line.
The in vitro cytotoxicity, by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay, of H. spicatum rhizome chloroform extract was assessed against colorectal adenocarcinoma
(Colo-205) cell line, human epidermoid carcinoma (A-431) cell line, human breast adenocarcinoma
(MCF-7) cell line, human lung adenocarcinoma (A549) and Chinese hamster ovary (CHO) cell lines [83].
The results show that the extract presented cytotoxicity against all cell lines exhibiting IC50 values
ranging from 37.45 ± 0.90 µg/mL to 63.21 ± 1.19 µg/mL, including against non-tumor cell line CHO
(39.52 ± 0.06 µg/mL), indicating that the H. spicatum rhizome chloroform extract have small potential
as a good anticancer drug since it affected in a similar way both tumor and non-tumor cell lines.
Results like these shows how difficult it is to find an ideal anti-tumor drug that affect only the tumor
cells, leaving the non-tumor cells undamaged. In addition, it would have been interesting if the authors
had also tested a reference compound, since it would have enriched their work.
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2.7. Hepatoprotective
The liver is a vital organ, capable of detoxifying the body from endogenous and/or exogenous
substances detrimental to the organism, and which is responsible for the regulation of diverse functions
and physiological processes, such as the metabolism of carbohydrates and fats and the secretion of
bile [84]. Exposure to drugs and chemicals can cause liver injury which, taking into account all the
functions inherent to the liver, is a major health problem [85]. Thus, compounds that can protect the
liver, stimulate hepatic function or help to regenerate hepatic cells, while simultaneously being less
toxic and more effective are of great interest, with natural sources being identified as good search
option [86].
A study [87] indicated that H. spicatum possess hepatoprotective properties since its three
rhizome extracts (methanolic, ethanolic and aqueous) exerted protection on HepG2 cells against
paracetamol-induced toxicity. The IC50 values were 282, 356 and 515 µg/mL for the methanolic,
ethanolic and aqueous extracts, respectively, which translates in a cytoprotection percentage of 16%,
13% and 9%, respectively. Compared to the 19% cytoprotection provided by the control substance
silymarin (IC50 = 110 µg/mL), the hepatoprotective effect of the extracts is not huge but it is worth
mentioning at least the methanolic extract.
A study which was also carried out to evaluate the potential hepatoprotective effect was the
in vivo study [88]. where cockerels were fed for 16 weeks with rhizome powder of H. spicatum,
while simultaneously receiving a dose of indoxacarb intended to cause chronic toxicity. The results of
the liver analysis show that, when compared with the control group (indoxacarb administration without
the added H. spicatum rhizome powder to the cockerels diet), H. spicatum rhizome ameliorated the
damages caused in cockerels by indoxacarb in the duration of the experiment. Apparently, the treatment
with H. spicatum modulated the expression levels of several different hepatic genes, such as those
involved in metabolization of indoxacarb (cytochrome P450 1A1), in the immune system (interleukin
6 (IL-6)) and in antioxidant function (catalase (CAT), superoxide dismutase (SOD) and glutathione
peroxidase (GPx)).
2.8. Insecticide
Control of mosquito population is crucial, particularly in developing countries, since they act as
vectors of several pathogens and parasites responsible for various worrisome diseases, e.g., dengue,
filariasis, malaria, West Nile or yellow fever [89,90]. In order to reduce or eliminate the human
contact with the vector, a wide range of methods exists with insecticides being a top choice in case of
mosquitoes [91]. However, with insecticide resistance being a problem in recent years [92], the search
for better substances with insecticide potential is imperative.
Kalimuthu and colleagues [93] carried out an interesting work where H. coronarium-synthesized
silver nanoparticles (AgNPs) were produced and their toxicity towards larvae and pupae of the dengue
vector Aedes aegypti was assessed, as well as their synergy with Mesocyclops formosanus predation over
A. aegypti larvae. The toxicity of aqueous H. coronarium rhizome extract was also assessed. The results
indicate that both H. coronarium formulations tested, aqueous rhizome extract and AgNPs, were toxic
against A. aegypti in a dose-dependent manner. Aqueous H. coronarium rhizome extract caused toxicity
with LC50 values from 0.688% against larval instar I to 1.882% dose against pupae stage of A. aegypti,
while AgNPs demonstrated its toxicity with LC50 values varying from 24.264 ppm for larval instar I till
348.68 ppm for pupae of A. aegypti. Once again, we are faced with a work whose authors express results
in non-comparable units and do not provide the necessary data for their conversion, significantly
reducing the impact of this work. Nevertheless, AgNPs were found to be stable over time in aquatic
environment and since a positive synergy was reported with M. formosanus predation on young
A. aegypti larvae, its combined use could lead to a higher efficacy in removing the larval population of
dengue mosquitoes from aquatic areas.
In another work [94], Hedychium larsenii M. Dan and C. Sathish Kumar rhizomes essential
oil was evaluated regarding its toxicity against larvae of mosquito vectors of diseases, namely
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Anopheles stephensi (malaria), A. aegypti (dengue) and Culex quinquefasciatus (St. Louis encephalitis).
The results demonstrate that the essential oil exerted larvicidal activity over the different larvae with
the LC50 values of 82.02, 88.60 and 96.40 µg/mL for A. stephensi, A. aegypti and C. quinquefasciatus,
respectively. Again, the lack of a tested reference compound impairs any conclusion taken from
these results.
3. Secondary Metabolites from Hedychium Species and Its Activities
The diverse bioactivities observed on different Hedychium species/extracts are intrinsically linked
to the compounds present in each one, so the need and interest in the phytochemical study of these
extracts/species becomes clear. Several relevant works managed to isolate compounds from Hedychium
extracts and carried out different assays to ascertain the bioactive potentials of those compounds.
In Table 2 the compounds isolated from Hedychium extracts are gathered, as well as their bioactivities
and the Hedychium species where they have already been identified. A figure with the chemical
structures of the compounds (Figure 1) listed in this table is present after Table 2. It should be clarified
that, for each compound in Table 2, only the highest activity value for each activity from each reference is
presented, with some values converted from µg/mL to µM to facilitate comprehension and comparison
of the different activities.
Table 2. Secondary metabolites isolated from Hedychium extracts with proven activities.
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Antitumor against NCI-H187 cell line (IC50 = 36.78 µM;
Vero cell line IC50 = 108.61 µM with SI of 2.9; ellipticine
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Antitumor against S102 cell line (IC50 = 25.13 µM **) [98];
Antitumor against P388 cell line (IC50 = 4.40 µM **;
Etoposide IC50 = 0.12 µM **)
[97];
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[98] H. coronarium rhizome [98]
Antitumor against HepG2 cell line (IC50 = 46.18 µM **)
[98]
Coronarin B (9) Dichloromethane [97];Hexane [98]
H. coronarium rhizome
[97,98]
Antitumor against MOLT-3 cell line (IC50 = 1.32 µM **;
Etoposide IC50 = 0.03 µM **) [97]
Coronarin D
acetate (10) Dichloromethane [97] H. coronarium rhizome [97]
Antitumor against P388 cell line (IC50 = 4.72 µM **;
etoposide IC50 = 0.12 µM **)
[97]
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Antitumor against P388D1 cell line (IC50 = 24.56 ± 1.92
µM **; doxorubicin IC50 = 0.74 ± 0.11 µM **) [102]
Coronarin A (17) Hexane [95];Methanol [102]
H. gardnerianum
rhizome [95]; H. coronarium
aerial part [102]
Antitumor against NCI-H187 cell line (IC50 = 40.77 µM;
Vero cell line IC50 = 150.45 µM with SI of 3.7; ellipticine
IC50 = 1.79 µM) [95];
Antitumor against DLD-1 cell line (IC50= 41.61 ± 6.32
µM **; doxorubicin IC50 = 0.39 ± 0.07 µM **) [102]
9-Hydroxy
hedychenone (18) Chloroform [83] H. spicatum rhizome [83]
Antitumor against Colo-205 cell line
(IC50 = 76.40 ± 0.03 µM **) [83];
Antitumor against CHO cell line
(IC50 = 49.87 ± 0.29 µM **) [83]
Hedychilactone B
(19) Chloroform [83] H. spicatum rhizome [83]
Antitumor against Colo-205 cell line
(IC50 = 86.55 ± 0.06 µM **) [83];
Antitumor against CHO cell line
(IC50 = 60.94 ± 0.25 µM **) [83]
Hedychilactone C
(20) Chloroform [83] H. spicatum rhizome [83]
Antitumor against Colo-205 cell line
(IC50 = 111.73 ± 0.09 µM **) [83];
Antitumor against CHO cell line
(IC50 = 70.82 ± 0.24 µM **) [83]
Hedychilactone
D (21) Chloroform [83]
H. spicatum rhizome
[83]
Antitumor against Colo-205 cell line
(IC50 = 36.41 ± 0.09 µM **) [83];
Antitumor against CHO cell line
(IC50 = 23.27 ± 3.39 µM **) [83]
Chrysin (22) Chloroform [83] H. spicatum rhizome[83]
Antitumor against Colo-205 cell line
(IC50 = 117.25 ± 0.24 µM **) [83];
Antitumor against CHO cell line
(IC50 = 83.94 ± 4.37 µM **) [83]
Teptochrysin (23) Chloroform [83] H. spicatum rhizome[83]
Antitumor against Colo-205 cell line
(IC50 = 122.63 ± 0.11 µM **) [83];
Antitumor against CHO cell line
(IC50 = 110.86 ± 0.15 µM **) [83]
Hedychin C (24) Ethanol [103] H. forrestii rhizome [103] Antitumor against XWLC-05 cell line (IC50 = 53.6 µM)[103]
Coronarin E (25) Hexane [95] H. gardnerianum rhizome[95]
Antitumor against NCI-H187 cell line (IC50 = 49.73 µM;
Vero cell line IC50 = 164.19 µM with SI of 3.3; ellipticine
IC50 = 1.79 µM) [95]
Villosin (26) Dichloromethane [95] H. gardnerianum rhizome[95]
Antitumor against NCI-H187 cell line (IC50 = 0.40 µM;
Vero cell line IC50 > 166.42 µM with SI > 416; ellipticine
IC50 = 1.79 µM) [95]
Yunnancoronarin
B (27) Hexane [95]
H. gardnerianum rhizome
[95]
Antitumor against NCI-H187 cell line (IC50 = 44.57 µM;
Vero cell line IC50 = 106.21 µM with SI of 2.4; ellipticine





Anti-depressant by MAO-A inhibition
(IC50 = 0.31 ± 0.05 µM) [105]
Salicylic acid (29) Acetone [104] H. gardenerianum rhizome[104] Anti-hemorrhagic (IC50 = 0.20 µM) [106]
* Only the highest activity value; ** Value after unit conversion from µg/mL to µM;
# MG132-carbobenzoxy-Leu-Leu-leucinal positive control; † The authors do not indicate the extract prepared.
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In addition to these compounds, hedyforrestin B (1) and hedyforrestin C (2) should also be
noted, since their antitumor activities against the NCI-H187 cell line are slightly lower (less than
1.7 times) than that shown by the reference compound ellipticine and with selectivity indices of 14.5 and
4.8, respectively.
On the other hand, compound isocoronarin D (11) should be highlighted since it exhibits
activity against a broad spectrum of tumor cell lines (i.e., A549, human cervical carcinoma (HeLa),
human hepatocellular carcinoma (HepG2), human acute promyelocytic leukemia (HL-60), human
cholangiocarcinoma (HuCCA-1), human epidermoid carcinoma (KB), human breast adenocarcinoma
(MDA-MB-231), human acute lymphoblastic leukemia T-lymphoblasts (MOLT-3), mouse lymphoma
neoplasm (P388), human hepatocellular carcinoma (S102) and human hormone-dependent breast
cancer (T-47D)), with IC50 values between 2.14 to 36.1 µM, better than etoposide or doxorubicin which
are toxic only to some of these cell lines, and being more active against HepG2 (IC50 = 16.6 µM) than
the reference compound etoposide (IC50 = 23.8 µM) [98].
Bearing in mind that all these compounds have hydroxyl groups and double bonds in their chemical
structure, it is suggested that these compounds could be lead compounds, and researchers in the field
of medicinal chemistry should use these labile functional groups to carry out structural modifications,
in order to obtain more active derivatives and to determine the structure/activity relationships.
In addition, there are some works which require a critical analysis. Zhao and colleagues [96]
isolated six labdanes from H. longipetalum rhizome that exhibited NO production inhibitory effects in
lipopolysaccharides (LPS) and interferon gamma (IFN-γ)-induced murine macrophages RAW 264.7 cell
line. The most active compound is yunnancoronarin A (6) (IC50 = 1.86 µM), but less active than the
positive control carbobenzoxy-Leu-Leu-leucinal (MG132) (IC50 = 0.17 µM). Unfortunately, the authors
do not mention the extraction and chromatographic procedures they carried out to isolate these
compounds, which would have been a valuable information.
Another study that looks promising, but which actually shows very questionable results,
is the one carried out by Kiem and colleagues [37]. They isolated compounds from rhizomes of
H. coronarium methanol extract and investigated their anti-inflammatory potential through inhibition
of pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells
(BMDC). The results are not acceptable and do not allow to infer conclusions since they are presented
with associated standard errors greater than 20% (e.g., IC50 IL-6 inhibition value = 7.57 ± 2.02 µM)
and in some cases close to 100% (e.g., IC50 IL-12p40 inhibition value = 0.19 ± 0.11 µM). This work [37]
was only mentioned here to point out to all authors the need to present reliable data in their works,
aiming always to show results with standard error less than 10%.
In other lines of work, several studies (e.g., Reddy et al. [83], Chimnoi et al. [98] and
Endringer et al. [101]) assessed the antitumor potential of isolated compounds from Hedychium extracts
without following the best guidelines for evaluating the cytotoxic potential of compounds. In fact,
the authors did not test a reference compound in the same experimental conditions, and did not test
the isolated compounds against a non-tumor cell line, which makes it difficult to draw conclusions.
Regrettably, without these results, it is not possible to conclude about the efficacy and selectivity of the
isolated compound compared to the drugs already available on the market.
In addition to compounds 28 and 29 (Figure 1), Carvalho and colleagues [104] also isolated the
compounds 3-(2-hydroxyethoxy)xanthone (30) and oplopanone (31) from H. gardenerianum rhizome
acetone extract, but the two compounds (Figure 2) do not present any reported activity and, therefore,
were not included in Table 2. Since they belong to families of organic compounds well-known for
their broad spectrum of activities (flavonoids and terpenes) [107], it would be worth investigating the
biological activity of these compounds.
It is a fact that the availability of a specific compound in a plant can depend on several
factors, like the geographic location where the plant developed [108] and/or the season when it
was harvested [109]. Thus, different studies can present different percentages of the total content
of the same compound which makes it difficult sometimes to make comparisons between the same
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plants. This fact is particularly relevant with regard to essential oils, where the majority of published
studies refers to quantitative chemical analysis. These studies reveal a complex composition and a
huge variability in the content of each compound, depending on geographic, seasonal and species
factors, which is reflected in the variability of the biological activity level of the respective essential oils,
already highlighted in point 2.
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Hedychium species are not different, with several compounds being identified with distinct
percentages on its essential oils. However, a deeper analysis of the published works allows to
identify some compounds that, with some slight differences, appear repeatedly as the most abundant
compounds in their essential oils. In Table 3 are gathered the five most abundant compounds identified
in essential oils from Hedychium species as well as their activities and the species where they have
already been identified. The respective structures are presented on Figure 3.
Table 3. The five most frequent and abundant chemical compounds identified in essential oils from
Hedychium species.
Compound Activity * Hedychium Source
1,8-Cineole
(32)
Antifungal against C. albicans (MIC = 203 µM **; nystatin
MIC = 135 µM **) [110]; Insecticide against Rhodnius
prolixus (KT50 = 117.2 min for 100 µL dose) [111]
H. coronarium rhizome [16,112]; Hedychium flavescens
Carey ex Rosc. rhizome [112]; Hedychium flavum
Roxb rhizome [112]; H. gardnerianum rhizome
[74]; H. gracile rhizome [73,112]; H. greenii rhizome
[73]; H. larsenii rhizome [94]; H. spicatum
rhizome [67,109,112]
α-Pinene (33)
Anti-acetylcholinesterase (IC50 = 10.50 ± 0.51 µM **;
ursolic acid IC50 = 0.416 ± 0.003 µM **) [50]; Anti-allergic
(dose of 10 mg/kg on mouse) [113]; Antidiabetic (dose of
0.25 mL/kg on mouse) [114]; Anti-inflammatory
(mouse ED50 = 0.039 mL/kg) [114]; Antimicrobial against
Streptococcus pneumoniae (MIC = 5 µL/mL; gentamicin
MIC = 21 µM **) [115]; Antitumor against A549 cell line
(IC50 = 161.56 ± 12.85 µM ** [116]
H. coccineum (syn. Hedychium aurantiacum Roscoe)
rhizome [112]; H. coronarium flower [117] and
rhizome [16,112]; H. flavescens rhizome [112];
H. flavum rhizome [112]; H. gardnerianum flower [118],
leaf [118] and rhizome [112]; H. greenii rhizome
[73,112]; H. matthewii rhizome [65]; H. spicatum
rhizome [109]
β-Pinene (34)
Antimicrobial against S. pneumoniae (MIC = 20 µL/mL;
gentamicin MIC = 21 µM **) [115]; Antitumor against
HCT-8 cell line (IC50 = 176.9 ± 2.9 µM **) [119]
H. coccineum (syn. H. aurantiacum) rhizome [112];
H. coronarium flower [117] and rhizome [16,108,112];
H. ellipticum rhizome [112]; H. flavescens rhizome
[112]; H. flavum rhizome [112]; H. gardnerianum flower
[118], leaf [118] and rhizome [112]; H. gracile rhizome
[73,112]; H. greenii rhizome [73]; H. larsenii rhizome
[94]; H. matthewii rhizome [65]; H. spicatum rhizome
[67,109]; Hedychium thyrisiforme Smith. rhizome [112]
Linalool (35)
Antibacterial against Bacillus mycoides (10 µL cause
11 mm inhibition zone; 10 µL of penicillin = 12 mm
inhibition zone) [120]
Antidepressive (dose of 100 mg/kg on mouse) [121];
Anti-inflammatory
(dose of 30 mg/kg on mouse) [122]; Antitumor against
U937 cell line (IC50 = 2.59 µM; 5-FU IC50 = 4.86 µM) [123];
Fumigant against Tribolium confusum larvae
(LC50 = 14.198 µL/L of air) [124];
Neuroprotective (100 µM reduced 30% OHSC cell death)
[125]
H. coronarium flower [117] and rhizome [108];
H. flavum rhizome [112];
H. larsenii rhizome [94];
H. matthewii rhizome [65];
H. spicatum rhizome [67,109]
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Compound Activity * Hedychium Source
Terpinen-4-ol
(36)
Antibacterial against Burkholderia pyriocinia (10 µL cause
8 mm inhibition zone; 10 µL of penicillin cause 9 mm
inhibition zone) [120]; Antifungal against Histoplasma
capsulatum (MIC = 129.70 µM **; AMB MIC = 0.54 µM **)
[126]; Antitumor against MCF-7 cell line (IC50= 18.02 µM
**; doxorubicin IC50 = 1.29 µM **) [127]
H. ellipticum rhizome [112];
H. gracile rhizome [73,112];
H. larsenii rhizome [94];
H. matthewii rhizome [65];
H. thyrisiforme rhizome [112]
* only the highest activity value; ** Value after unit conversion from µg/mL to µM.
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As it is possible to see on Table 3, linalool (35) proved to have promising antitumor potential since
it presented cytotoxicity against U937 cell line (i.e., IC50 = 2.59 µM), better than the positive control
5-FU against the same cell line (i.e., IC50 = 4.86 µM). It would have been interesting if the authors
had tested the compounds cytotoxicity against a non-tumor cell line, but unfortunately that was not
the case.
From the five most abundant and most frequent present compounds in essential oils of Hedychium
species,β-pinene (34) is the most widespread compound among species being identified in 12 Hedychium
species, mainly rhizomes but also in some cases from flower and leaf essential oil. The compounds
α-pinene (33) and linalool (35), exhibit a broad range of bioactivities, being anti-acetylcholinesterase,
anti-allergic, antidepressive, antidiabetic, anti-inflammatory, antimicrobial, antitumor, fumigant and
neuroprotective agents.
The antimicrobial activity of α-pinene (33), β-pinene (34) reported by Leite et al. [115] presented
in Table 3 should be noted, which appears as µL/mL and the authors do not provide the necessary
data to convert it to µM or µg/mL. Thus, it is impossible to compare the exhibited activity with other
published results and even to compare with the positive control used in this study.
Despite not being so abundant as the compounds referred in Table 3, the isolation of two
compounds from H. larsenii rhizomes essential oil could be mentioned, i.e., ar-curcumene (37) and
epi-β-bisabolol (38) (Figure 4), that presented insecticide properties against diseases mosquito vectors
larvae A. stephensi, A. aegypti and C. quinquefasciatus [94]. The results show that the most affected
vector was A. stephensi with compounds 37 and 38 presenting a LC50 values of 51.65 and 66.02 µM,
respectively. Unfortunately, the lack of a tested reference compound is a handicap in this work.
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bioactivities. This allows to easily identify where there is work already successfully developed and
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4. Conclusions
Hedychium genus is undoubtedly proven to be a valuable group of medicinal plants, being present
in several folk medicines around the world where it is known to treat allergies, cancer, diabetes,
inflammation, rheumatism and skin problems, as well as being also used as an analgesic, antimicrobial,
anti-helminthic, antioxidant and insect repellent. In addition, some Hedychium species are part of
human diet, being cooked as a vegetable, used as a spice or drunk as a beverage.
Several works explored Hedychium species in order to confirm if and how effectively these plants
exert the reported biological effects on folk medicine, studying their essential oils, extracts and their
isolated compounds. Taking into account the results of the literature in recent years, Hedychium
species have been proven to possess interesting pharmaceutical activities, i.e., anti-acetylcholinesterase,
antidiabetic, anti-inflammatory, antimicrobial, antioxidant, antitumor and hepatoprotective, as well as
having potential to develop insecticides.
Phytochemical works have been carried out in Hedychium, mainly on H. coronarium and H. spicatum,
but also on other less known species, leading to the isolation of interesting compounds that, in some
cases, proved to be better than reference compounds. An example is coronarin D (7), possessing
antifungal, antitumor and antibacterial properties, being more effective than the positive control
oxacillin against B. cereus in antibacterial assays. Isocoronarin D (11), villosin (26) and linalool (35)
can be pointed out as very promising antitumor compounds since they exhibited better cytotoxicity
towards tumor cell lines than the reference compounds used, and in case of villosin (26) without
toxicity on non-tumor cell line. Furthermore, the most bioactive compounds found in Hedychium
essential oils can be highlighted as α-pinene (33) and linalool (35), since they are reported as presenting
a wide spectrum of bioactivities. In addition, being identified in 12 different Hedychium species to this
date, β-pinene (34) is the most widespread compound in Hedychium essential oils.
Hedychium species as proved to be a very rich genus that can still have a lot to offer to the scientific
community. Moreover, the discovery in recent years of four new Hedychium species (i.e., Hedychium
chingmeianum N.Odyuo and D.K.Roy [128], Hedychium putaoense Y.H.Tan and H.B.Ding [129], Hedychium
viridibracteatum X.Hu [130] and Hedychium ziroense V.Gowda and Ashokan [131], may bring new
compounds with pharmaceutical potential to the equation.
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Abbreviations
A-431 Human epidermoid carcinoma
A549 Human lung adenocarcinoma
ABTS 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)
AChE Acetylcholinesterase
AgNPs H. coronarium-synthesized silver nanoparticles
BHT 2,6-di-tert-butyl-4-methylphenol
BMDC Bone marrow-derived dendritic cells
C57BKSdb/db
Strain of laboratory mouse with a mutation that results in chronic hyperglycemia, pancreatic
beta cell atrophy, low insulin level and obesity
CAT Catalase
CHO Chinese hamster ovary cells
Colo-205 Colorectal adenocarcinoma
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COX-1 Cyclooxygenase 1
DLD-1 Human colorectal carcinoma
DPPH 1,1-Diphenyl-2-picrylhydrazyl
EC50 Half maximal effective concentration
ED50 Half maximal effective dose
GPx Glutathione peroxidase
HeLa Human cervical carcinoma
HepG2 Human hepatocellular carcinoma
HL-60 Human acute promyelocytic leukemia
HuCCA-1 Human cholangiocarcinoma
HUVEC Human umbilical vascular endothelial cells
IC50 Half maximal inhibitory concentration
IFN-γ Interferon gamma
IL-6 Interleukin 6
Il-12p40 Interleukin-12 subunit p40
KB Human epidermoid carcinoma
KT50 Knockdown time 50%
LC50 Lethal concentration that kills 50% of exposed organisms
LNCaP Human prostate adenocarcinoma
LPS Lipopolysaccharide
MAO-A Monoamine oxidase A
MCF-7 Human breast adenocarcinoma
MDA-MB-231 Human breast adenocarcinoma
MG132 Carbobenzoxy-Leu-Leu-leucinal
MIC Minimum inhibitory concentration
MOLT-3 Human acute lymphoblastic leukemia T-lymphoblasts
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NCI-H187 Human classic small cell lung carcinoma
NF-κB Nuclear factor kappa-B
NO Nitric oxide
OHSC Organotypic hippocampal slice cultures
P388 Mouse lymphoma neoplasm
P388D1 Murine macrophage-like lymphoma
RAW 264.7 Murine macrophage
ROS Reactive oxygen species




T2DM Type 2 diabetes mellitus
T-47D Human hormone-dependent breast cancer
TNF-α Tumor necrosis factor α
U937 Human histiocytic lymphoma
Vero African green monkey kidney epithelial cells
XWLC-05 Human lung adenocarcinoma
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